Procuring entity image

RB2022-0117 - Läkemedel Bevacizumab

To participate visit Kommers Annons eLite and register interest. You may need to create a user account at Kommers Annons eLite if you do not already have one.

1. Contracting authority or entity

Official name
Region Blekinge
National registration number
232100 - 0081
Telephone
0455-73 10 00
Email address
region@regionblekinge.se
Joint procurement
No
Type of contracting authority or entity
Regional authority
Organisation role
Buyer
Main activity
Health
The contract is awarded by a central purchasing body
No
The procurement is conducted on behalf of an other entity
No

2. Object

Title
Läkemedel Bevacizumab
Reference number
RB2022-0117
Description
Läkemedel Bevacizumab
Main CPV-code
33600000-6 Läkemedel
Contract nature
Supplies
Estimated value
Information about lots
No lots
Additional CPV codes
33600000-6 - Läkemedel
Place of performance (NUTS-code)
SE221 Blekinge län
Contract period start
1/1/2023
Contract period end
12/31/2023
Options enabled
No
Options description

3. Legal, economic, financial and technical information

Legal basis
32014L0024
Environmental requirements
Other
Social requirements
Fair working conditions, Human rights due diligence in global supply chains, Ethnic equality, Other
Innovative requirements
Sheltered employment
No
Reserved procurement
Subject to law on procurement statistics
Yes

4. Procedure

Type of procedure
Open
Is direct procurement?
No
An electronic auction will be used
No
Accelerated procedure
No
A dynamic purchasing system is used
No
Information about dynamic purchasing system
The procurement concerns a framework agreement
Yes
Framework agreement type (if applicable)
Framework agreement, without reopening of competition
Time limit for receipt of tenders or requests to participate
11/25/2022
Tender valid till
3/25/2023

6. Complementary info

National procurement number
KA9568
Date for initial dispatch of the notice
10/25/2022
TED Notice number
2022/S 207-589951
Ted Notice